Grosse Pointe Shores, MI, United States of America

Ray O Bahado-Singh

This inventor holds 3 USPTO granted patents and 9 published patent applications. Top assignee: Bioscreening & Diagnostics LLC. Active years: 2020-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ray O Bahado-Singh. Retrieved from https://idiyas.com/inventor/ray-o-bahado-singh

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 3 

% Patents Active = 100.0

Average Co-Inventor Count = 1.2

ph-index = 1

Forward Citations = 2(Granted Patents)


Location History:

  • Gross Pointe Shores, MI (US) (2020)
  • Grosse Pointe Shores, MI (US) (2020 - 2024)

Company Filing History:


Years Active: 2020-2024

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Ray O Bahado-Singh: Innovator in Medical Diagnostics

Introduction

Ray O Bahado-Singh is a prominent inventor based in Gross Pointe Shores, MI (US). He has made significant contributions to the field of medical diagnostics, particularly in the detection of traumatic brain injuries and congenital heart defects. With a total of three patents to his name, his work is at the forefront of innovation in healthcare.

Latest Patents

One of his latest patents is a method for the detection of traumatic brain injury (TBI). This invention describes significant methylation changes in multiple genes and metabolites in body fluids in response to TBI. The gene pathways affected include several known to be involved in neurological and brain function. A large number of good to excellent biomarkers for the detection of TBI have been identified. The combination of epigenomic, clinical, and metabolomic markers in various combinations has proven to be highly accurate for detecting pediatric concussions using Artificial Intelligence-based techniques.

Another notable patent focuses on the metabolomic prediction of congenital heart defects during pregnancy, as well as in newborn and pediatric stages. This invention outlines methods for assaying metabolite levels in samples from patients during pregnancy using nuclear magnetic resonance and direct flow injection mass spectrometry. The assayed metabolites may include acylcarnitine or specific compounds such as C3-OH, C5-OH, C10, C5:1-DC, C14:1-OH, and C14:2-OH. Additionally, the methods may involve measuring the nuchal translucency of the fetus, which relates to predicting fetal congenital heart defects.

Career Highlights

Ray O Bahado-Singh is currently associated with Bioscreening & Diagnostics LLC, where he continues to innovate in the field of medical diagnostics. His work has garnered attention for its potential to improve patient outcomes through early detection and intervention.

Collaborations

His notable coworker in these endeavors is Kypros Nicolaides, who shares a commitment to advancing medical research and diagnostics.

Conclusion

Ray O Bahado-Singh's contributions to medical diagnostics through his innovative patents highlight the importance of research and development in healthcare. His work not only enhances our understanding of traumatic brain injuries and congenital heart defects but also paves the way for future advancements in medical technology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…